Format

Send to

Choose Destination
J Infect Dis. 2017 Mar 15;215(6):844-846. doi: 10.1093/infdis/jix006.

Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.

Author information

1
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

KEYWORDS:

genital herpes; herpes simplex; vaccine; prophylaxis

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center